The rationale behind utilizing RFA in MTC treatment stems from its minimally invasive nature and potential to effectively reduce tumor size while preserving surrounding healthy tissue and also decrease the serum level of calcitonin [6]. This evidence concerns the gene CALCA and medullary thyroid gland carcinoma.